From our sponsor SafeMinds: NIMH Autism Webcast Thursday - "Advances in Treatment Research"
This one-hour webcast on Thursday, April 21st from 10:30-11:30 am EDT will be of interest to many of you. Both Dr. Swedo and Dr. Landa are active autism researchers. The presentation will be video archived for those who can't watch Thursday morning.
The Office of Autism Research Coordination (OARC), NIMH is pleased to be co-sponsoring the National Institute of Mental Health (NIMH) Autism Awareness Month Seminar: "Advances in Treatment Research." This event is open to the public, both in-person and by webcast.
The seminar will feature presentations by Dr. Susan Swedo and Dr. Rebecca Landa about their research on innovative drug and behavioral treatments for autism spectrum disorder. For speaker biosketches, please see below.
Date: Thursday, April 21, 2011
Time: 10:30-11:30 am ET
Location: The Neuroscience Center
Conference Room C
6001 Executive Boulevard
Rockville, Maryland 20852
Webcast Live: http://videocast.nih.gov/summary.asp?live=10144 (seems this link will not be working until the event.)
For in-person attendees, seating is on a first come, first served basis. The event will also be videocast live and archived through NIH Videocast: http://videocast.nih.gov/summary.asp?live=10144 for remote access.
Individuals with disabilities who need Sign Language Interpreters and/or reasonable accommodation to participate in this event should contact Christine Kaucher,Kaucherc@mail.nih.gov, 301-443-4058, and/or the Federal Relay (1-800-877-8339).
Please send questions about this event to email@example.com. We look forward to your participation on April 21st!
Susan Swedo, M.D.
Dr. Susan Swedo is Chief of the Pediatrics & Developmental Neuropsychiatry Branch, NIMH. She is a board-certified pediatrician, who trained at Northwestern University's Children's Memorial Hospital in Chicago, Illinois. Dr. Swedo has authored/co-authored over 100 research publications since joining the NIMH in 1986. Her research has focused on diagnosis and treatment of childhood neuropsychiatric conditions, including Sydenham's chorea, Tourette Syndrome, Obsessive-Compulsive Disorder (OCD), and autism spectrum disorders. Dr. Swedo and colleagues were the first to describe a post-infectious etiology for OCD and define criteria identifying the PANDAS subgroup (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections). Current research efforts are directed at identifying biological causes for behavioral syndromes and developing new and more effective therapies. Dr. Swedo received her B.A. degree from Augustana College in 1977 and her M.D. from Southern Illinois University in 1980.
Rebecca Landa, Ph.D., CCC-SLP
Dr. Rebecca Landa is the founder and director of Kennedy Krieger's Center for Autism and Related Disorders. She is an associate Professor of Psychiatry in the Johns Hopkins University School of Medicine. Dr. Landa obtained her master's degree at the Pennsylvania State University and her doctorate at the University of Washington. She completed post-doctoral training in Psychiatric Genetics at Johns Hopkins. She is the recipient of the NIMH Shannon Award for excellent and innovative research, as well as the Rita Rudel Prize for Developmental Neuropsychology. Dr. Landa is the recipient of the 2009 Alumni Recognition Award from the College of Human Health and Development of the Pennsylvania State University.
Dr. Landa's research has focused on neuropsychological, learning, and communication processes in autism across the lifespan. She was the principal investigator of an NIH STAART Center of Excellence, through which she developed and defined the evidence-base for the Early Achievements intervention for toddlers with autism spectrum disorders. She has pioneered research aimed at identifying the earliest signs of autism through the study of infant siblings of children with autism. Dr. Landa is the author of the Pragmatic Rating Scale, used internationally in autism-related research and clinical practice. Her current research focus is on learning processes in autism, as well as early detection of and intervention for autism spectrum disorders (ASD).
The treatment category is sponsored by Lee Silsby, the leader in quality compounded medications for autism.